MedPath

Solyx Single-Incision SlingDynamic Intraoperative Standing Sling Technique (DISST) as an Office-based Procedure

Not Applicable
Active, not recruiting
Conditions
Stress Urinary Incontinence
Interventions
Device: Single-Incision Sling
Registration Number
NCT03842410
Lead Sponsor
Michigan Institution of Women's Health PC
Brief Summary

This study will assess the feasibility and success of performing the SolyxTM SIMUS in the office using the Dynamic Interactive Standing Sling Technique (DISSTTM). Study endpoints will be feasibility, composite success, complications, and patient and physician acceptance.

Detailed Description

The single-incision midurethral sling (SIMUS) is a procedure where there are no exit incisions. There is a 15 mm suburethral incision with the sling being attached with anchors to the obturator muscle on each side. This procedure has potentially lesser side-effects compared to the longer slings however, the literature has not found the SIMUS to be as effective as the long slings. In our recently published study, the DISSTTM technique has significantly improved the success of the SIMUS procedure as the sling can be tested for proper application in vivo.

As we have performed several of these procedures in the operating room entirely under local anesthesia, we have decided to perform this procedure in an office setting using the same safety precautions as in a hospital operating room.

Performing this procedure in the office has significant benefits for the patient, the healthcare industry, and the economy overall. Moving away from a hospital setting has significant psychological benefits. This will increase patient acceptance and therefore will become appealing to many more women who may be shying away from treatment.

It would also eliminate the risk of nosocomial infections for the patient and family members, improve efficiency as the wait time would be negligible, and would reduce the expense of the entire treatment as hospital costs would not feature in the equation.

This study will assess the feasibility and success of performing the SolyxTM SIMUS in the office using the Dynamic Interactive Standing Sling Technique (DISSTTM). Study endpoints will be feasibility, composite success, complications, and patient and physician acceptance.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • SUI with hypermobility of the urethrovesical (UV) junction
  • American Society of Anesthesiologists (ASA) classes I or II
  • Ages ranging 21-89 years
  • Have the ability to stand for CST during the procedure
  • Have failed behavioral therapy
  • Completed childbearing
Exclusion Criteria
  • ASA classes III or IV
  • Need for concomitant surgery
  • Poor compliance for office-based approach
  • Demonstrate concomitant urgency incontinence on urodynamic testing

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Single-Incision SlingSingle-Incision SlingIntervention with in office solyx suburethral sling DISST
Primary Outcome Measures
NameTimeMethod
Subject tolerability of the Solyx SIMUS in the office using the Dynamic Interactive Standing Sling Technique (DISST)intraoperative

Subject tolerability will be assessed using a 10-cm Visual Analogue Scale rating tolerability of the procedure. The Visual Analog Scale measures discomfort of the procedure with 0 being no discomfort and 10 being severe discomfort.

Surgeon difficulty of performing the Solyx SIMUS in the office using the Dynamic Interactive Standing Sling Technique (DISST)intraoperative

Surgeon difficulty will be determined by a 5-point Likert scale ranging from 1 (very easy) to 5 (very difficult).

Ability to achieve DISST SUCCESSintraoperative

Defined as a negative intraoperative standing cough stress test (CST) at bladder fullness.

Complications of performing the Solyx SIMUS in the office using the Dynamic Interactive Standing Sling Technique (DISST)intraoperative

Any intraoperative complications will be documented

Secondary Outcome Measures
NameTimeMethod
Improvement in overall urinary incontinence (stress and urge incontinence)3, 6, 12, 24 and 60 months post operative

Subject will complete the Medical, Epidemiologic, and Social Aspects of Aging (MESA) urinary incontinence questionnaire to assess improvement in urge incontinence and stress incontinence. Subjects will also complete the Patient Global Impression of Improvement (PGI-I) questionnaire as it pertains to stress urinary incontinence.

Improvement in patient quality of life as it relates to urinary symptoms3, 6,12, 24 and 60 months post operative

Subject will complete Incontinence Impact Questionnaire (IIQ-7) to assess changes in quality of life related to urinary symptoms.

Post operative complicationspost procedure to 12, 24 and 60 months

At post operative visits patients will be asked and assessed for post operative complications (based upon the Clavien Dindo classification)

Sexual function3, 6,12, 24 and 60 months post operative

Subject will complete the Pelvic Organ Prolapse/Urinary Incontinence Sexual (PISQ-12) questionnaire to assess changes in sexual function.

Subject satisfaction with overall improvement from sling procedure3, 6, 12, 24 and 60 months post operative

Subject will completed satisfaction questionnaire to determine patients overall satisfaction with the procedure and results

Post operative painpre-procedure to 7 days after procedure

Post operative pain will be assessed using a McCarthy pain scale questionnaire, which ranges from "No Pain Sensation" to "Most Intense Pain Sensation Imaginable". Pain will be assessed at rest, during daily activities, during sex, lifting, or other strenuous work in the last 24 hours. This will be completed prior to surgery, the day of, and the 7 days following surgery.

Return to pre-surgical activitiesPre-procedure to return to 60 months

Patients will be asked what activities they engage in prior to surgery including work, exercise, social, and household activities. At each post operative visit the patient will be asked when they returned to pre-surgical activities.

Trial Locations

Locations (1)

Advanced Urogynecology of Michigan P.C

🇺🇸

Dearborn, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath